FindTrial
Sign In

TO KNOW THE INCIDENCE OF CARDIOVASCULAR ABNORMALITY IN HYPERTENSIVE PATIENTS UNDERGOING NEUROSURGICAL PROCEDURES:

INCIDENCE OF CARDIOVASCULAR ABNORMALITY IN HYPERTENSIVE PATIENTS UNDERGOING NEUROSURGICAL PROCEDURES: A PROSPECTIVE, OBSERVATIONAL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/037893
Enrollment
75
Registered
2021-11-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C719- Malignant neoplasm of brain, unspecified

Interventions

Control Intervention1: NIL: NIL

Sponsors

PGIMER Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hypertensive patients undergoing an intracranial neurosurgical procedure ASA PS 2 GCS 15/15

Exclusion criteria

Exclusion criteria: Pre-existing coronary artery disease (CAD) and active cardiac condition History of chronic liver disease, chronic kidney disease and chronic obstructive airway disease

Design outcomes

Primary

MeasureTime frame
The study aimed to evaluate the incidence of cardiovascular abnormality with transthoracic echocardiography (pre operative) in hypertensive patients undergoing neurosurgical procedures.Timepoint: Baseline , one day after surgery, 7 days after surgery—

Secondary

MeasureTime frame
Incidence of reversibility of cardiovascular abnormality through TTE at discharge or 7 days. Corelation of cardiovascular abnormality with duration of hypertension and intracranial pathologyTimepoint: Baseline and one day and seven day after surgery—

Countries

India

Contacts

Public ContactShiv lal Soni

PGIMER Chandigarh

dr.shivsoni@gmail.com01722756500

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026